Pierre Tennstedt
Overview
Explore the profile of Pierre Tennstedt including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
106
Citations
2017
Followers
0
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Falkenbach F, Mazzucato G, Tian Z, Karakiewicz P, Graefen M, Steuber T, et al.
Eur Urol Open Sci
. 2025 Jan;
70():1-7.
PMID: 39822239
Background And Objective: In patients with oligorecurrent prostate cancer (PCa), prostate-specific membrane antigen-targeted radioguided surgery (PSMA-RGS) prolongs treatment-free survival. Data on patient-reported outcome measures (PROMs) are lacking. Methods: A retrospective...
2.
Mazzucato G, Falkenbach F, Schmalhofer M, Shenas F, Cerruto M, Antonelli A, et al.
Cancers (Basel)
. 2025 Jan;
17(1.
PMID: 39796722
Background: To examine the feasibility and safety of the SENSEI drop-in gamma probe for robot-assisted, prostate-specific membrane antigen (PSMA)-radioguided salvage surgery (RGS) in lymph node or local oligorecurrent prostate cancer...
3.
Ambrosini F, Hagemann J, Pose R, Maurer T, Heinzer H, Michl U, et al.
World J Urol
. 2024 Dec;
43(1):7.
PMID: 39621043
Objectives: To determine the surgical and oncologic outcomes of salvage radical prostatectomy (sRP) after FT failure. Materials And Methods: Patients who consecutively underwent primary RP or sRP after FT failure...
4.
Brown R, Beyer B, Knipper S, Mehring G, Budaus L, Tennstedt P, et al.
World J Urol
. 2024 Nov;
42(1):640.
PMID: 39549095
Purpose: The aim of our study was to investigate the impact of the time interval between prostate biopsy and radical prostatectomy (RP) on postoperative urinary continence (UC)/erectile function (EF). From...
5.
Ambrosini F, Preisser F, Tilki D, Heinzer H, Salomon G, Michl U, et al.
Prostate Cancer Prostatic Dis
. 2024 Jun;
PMID: 38862777
Objectives: To evaluate the long-term oncological outcomes and functional results of the neurovascular structure-adjacent frozen-section examination (NeuroSAFE) during nerve-sparing (NS) radical prostatectomy (RP). Materials And Methods: A 10-yr survival analysis...
6.
Knipper S, Lischewski F, Koehler D, Eiber M, van Leeuwen F, de Barros H, et al.
Eur Urol Oncol
. 2024 May;
PMID: 38729805
Background: In a subset of patients with oligorecurrent prostate cancer (PCa), salvage surgery with prostate-specific membrane antigen (PSMA) radioguided surgery (PSMA-RGS) seems to be of value. Objective: To evaluate whether...
7.
Filipas D, Pose R, Marks P, Tennstedt P, Beyer B, Tilki D, et al.
Aging Male
. 2024 May;
27(1):2347465.
PMID: 38712892
Purpose: This study investigates how the COVID-19 pandemic (CP) impacted the timeline between initial diagnosis (ID) of prostate carcinoma and subsequent therapy consultation (TC) or radical prostatectomy (RP) due to...
8.
Ambrosini F, Knipper S, Tilki D, Heinzer H, Salomon G, Michl U, et al.
World J Urol
. 2024 Mar;
42(1):131.
PMID: 38478106
Purpose: To compare oncological, functional, and surgical outcomes of a large cohort of patients who underwent open retropubic radical prostatectomy (ORP) or robot-assisted radical prostatectomy (RARP). Materials And Methods: Data...
9.
Pose R, Knipper S, Ekrutt J, Kolker M, Tennstedt P, Heinzer H, et al.
Asian J Urol
. 2024 Feb;
11(1):42-47.
PMID: 38312827
Objective: To examine the perioperative impact of factor V Leiden mutation on thromboembolic events' risk in radical prostatectomy (RP) patients. With an incidence of about 5%, factor V Leiden mutation...
10.
Falkenbach F, Ambrosini F, Tennstedt P, Eiber M, Heck M, Preisser F, et al.
Cancers (Basel)
. 2023 Oct;
15(20).
PMID: 37894375
Objective: To assess the influence of biochemical recurrence (BCR) risk groups and PSA kinetics on the outcomes of radioguided surgery against prostate-specific membrane antigen (PSMA-RGS). Currently, neither BCR risk group...